Radium Ra-223 Dichloride
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Radium Ra-223 Dichloride, covering 2018-02-01 to 2019-03-19. Get the full timeline:
Most recent: Clinical Trial Update: Open Label Phase Two Study of Enzalutamide With Concurrent Administration of Radium Ra 223 Dichloride in Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Symptomatic Bone Metastasis [Phase 2]